This is a preview of subscription content, log in via an institution to check access.
Reference
Aranda-Reneo I, et al. Can the Consideration of Societal Costs Change the Recommendation of Economic Evaluations in the Field of Rare Diseases? An Empirical Analysis Value in Health : 5 Dec 2020. Available from: URL: https://doi.org/10.1016/j.jval.2020.10.014
Rights and permissions
About this article
Cite this article
Societal perspective has little impact on CEA results in rare diseases. PharmacoEcon Outcomes News 868, 31 (2020). https://doi.org/10.1007/s40274-020-7363-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-020-7363-7